Abstract
Interest in upfront thoracic endovascular aortic repair (TEVAR) for acute uncomplicated type B aortic dissection (uTBAD) has grown despite few supporting multicenter randomized data in the U.S. population. We sought to compare cardiovascular outcomes after a strategy of upfront TEVAR vs upfront medical therapy in patients with uTBAD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
